• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.62% Nasdaq Up0.35%

    More On SAZ.DE



    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Stada-Arzneimittel AG (SAZ.DE)

    29.28 Up 0.49(1.70%) Feb 10
    ProfileGet Profile for:
    Stada-Arzneimittel AG
    Stadastrasse 2-18
    Bad Vilbel, 61118
    Germany - Map
    Phone: 49 6101 6030
    Fax: 49 6101 603 259
    Website: http://www.stada.de

    Index Membership:N/A
    Industry:Drugs - Generic
    Full Time Employees:10,447

    Business Summary 

    STADA Arzneimittel AG engages in the development and marketing of active pharmaceutical ingredients for the health care and pharmaceutical markets worldwide. The company operates in two segments, Generics and Branded Products. The Generics segment provides various active ingredients, including stomach medicines, antihypertensive agents, and anti-inflammatory agents. This segmentÂ’s principal products include Omeprazole, a stomach medicine; Diclofenac, an antirheumatic drug; Tilidine, an opioid; Atorvastatin, an antilipemic; and Phospholipide, a liver medicine. The Branded Products segment offers non-prescription products. This segment primarily provides APO-go, a Parkinson medicine; Aqualor, a cold medicine based on seawater; Grippostad, a cold medicine; Snup, a nasal preparation; and Ladival, a sunscreen product. It serves patients and/or consumers, doctors, doctorsÂ’ cooperatives, pharmacies, pharmacy co-operatives, hospitals, wholesalers, and other service providers in the health care market, as well as public health insurance organizations or private insurances. The company was founded in 1895 and is headquartered in Bad Vilbel, Germany.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Stada-Arzneimittel AG

    Key Executives 
    Mr. Hartmut Retzlaff , 63
    Chairman of The Exec. Board
    Mr. Helmut Kraft , 57
    Chief Financial Officer and Member of Exec. Board
    Dr. Matthias Wiedenfels , 43
    Chief Bus. Devel. & Central Services Officer and Member of Exec. Board
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in EUR.